Holen Sie sich die Stockscreener-App
27.80
0.11%
0.0644
Schlusskurs vom Vortag:
$27.74
Offen:
$27.84
24-Stunden-Volumen:
423.35K
Relative Volume:
0.50
Marktkapitalisierung:
$1.61B
Einnahmen:
$868.45M
Nettoeinkommen (Verlust:
$158.69M
KGV:
10.26
EPS:
2.7087
Netto-Cashflow:
$328.64M
1W Leistung:
+3.24%
1M Leistung:
-1.97%
6M Leistung:
+4.44%
1J Leistung:
-5.09%
1-Tages-Spanne:
$27.46
$28.05
1-Wochen-Bereich:
$27.18
$28.63
52-Wochen-Spanne:
$25.52
$40.87
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
Firmenname
Harmony Biosciences Holdings Inc
Sektor
Branche
Telefon
(484) 539-9800
Adresse
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Compare HRMY vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
27.77 | 1.60B | 868.45M | 158.69M | 328.64M | 2.7087 |
VRTX
Vertex Pharmaceuticals Inc
|
435.51 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
758.77 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.89 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.62 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
164.96 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-23 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2026-02-23 | Herabstufung | Truist | Buy → Hold |
| 2026-02-11 | Fortgesetzt | UBS | Neutral |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-12-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-10 | Fortgesetzt | Raymond James | Outperform |
| 2024-09-10 | Eingeleitet | UBS | Buy |
| 2024-06-21 | Eingeleitet | Citigroup | Buy |
| 2024-01-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-09-25 | Herabstufung | Goldman | Neutral → Sell |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-20 | Eingeleitet | BofA Securities | Neutral |
| 2022-10-14 | Hochstufung | Janney | Neutral → Buy |
| 2022-10-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-13 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-12-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-04 | Eingeleitet | Raymond James | Outperform |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2021-03-29 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-14 | Eingeleitet | Goldman | Neutral |
| 2020-09-14 | Eingeleitet | Jefferies | Buy |
| 2020-09-14 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten
Harmony Biosciences Holdings, I (HRMY) Stock forecasts - Yahoo Finance UK
Harmony Biosciences Holdings, Inc. ($HRMY) CEO 2025 Pay Revealed - Quiver Quantitative
Harmony Biosciences Holdings, Inc. (HRMY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Harmony Biosciences Holdings, Inc. (HRMY) stock price, news, quote and history - Yahoo Finance Singapore
Harmony Biosciences Holdings (HRMY) Valuation After New COO And Board Appointments - Yahoo Finance
Harmony Biosciences Appoints Peter Anastasiou as Chief Operating Officer - The Globe and Mail
[ARS] Harmony Biosciences Holdings, Inc. SEC Filing - Stock Titan
Executive pay and board elections at Harmony Biosciences (HRMY) 2026 virtual meeting - Stock Titan
A Look At Harmony Biosciences Holdings (HRMY) Valuation After Recent Share Price Weakness - Sahm
Harmony Biosciences names Peter Anastasiou as chief operating officer By Investing.com - Investing.com India
Harmony Biosciences Holdings, Inc. (HRMY) Latest Stock News & Headlines - Yahoo Finance
Harmony Biosciences Holdings, Inc. Announces Management Changes - marketscreener.com
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board - BioSpace
Harmony Biosciences names Peter Anastasiou as chief operating officer - Investing.com
Harmony Biosciences Holdings, Inc. recently announced two significant personnel changes aimed at strengthening the company’s governance and strategic leadership. - Bitget
Harmony Biosciences (HRMY) names new COO and reshapes its board - Stock Titan
Harmony taps new COO while longtime director skips re-election - Stock Titan
Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference - Investing News Network
Wedge Capital Management L L P NC Buys New Position in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Aug Rallies: Is Harmony Biosciences Holdings Inc part of any ETF2026 Investor Takeaways & Precise Trade Entry Recommendations - baoquankhu1.vn
Pharma News: Can Harmony Biosciences Holdings Inc reach all time highs this year2026 Sentiment & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Harmony Biosciences stock faces headwinds amid analyst downgrade and Q4 earnings miss - AD HOC NEWS
Harmony Biosciences (NASDAQ:HRMY) Stock Rating Lowered by Zacks Research - MarketBeat
Vanguard disaggregates holdings after realignment — Harmony Biosciences (HRMY) - Stock Titan
SG Americas Securities LLC Increases Stock Holdings in Harmony Biosciences Holdings, Inc. $HRMY - MarketBeat
Top 5 US Stocks To Buy In April 2026 - Investing.com
Harmony Biosciences stock faces pipeline scrutiny amid Polaryx integration challenges and rare disea - AD HOC NEWS
Market Outlook: Does Harmony Biosciences Holdings Inc offer margin of safetyWeekly Trade Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Are options traders betting on a big move in Harmony Biosciences stock? - MSN
Harmony Biosciences to report Q4 and full-year 2025 results - MSN
HRMY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
HRMY Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Are Options Investors Anticipating Significant Volatility in Harmony Biosciences Shares? - Bitget
Are Options Traders Betting on a Big Move in Harmony Biosciences Stock? - TradingView
(HRMY) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Bull Bear: Is Harmony Biosciences Holdings Inc impacted by rising ratesTrade Risk Report & Long-Term Investment Growth Plans - baoquankhu1.vn
Harmony Biosciences targets $1B–$1.04B WAKIX revenue in 2026 while expanding late-stage CNS pipeline - MSN
FOMO Trade: Can Harmony Biosciences Holdings Inc reach all time highs this year2026 Sector Review & Momentum Based Trading Signals - baoquankhu1.vn
Can Harmony Biosciences Holdings Inc reach all time highs this year - baoquankhu1.vn
Harmony Biosciences tumbles following Deutsche Bank, Truist downgrades - MSN
Finanzdaten der Harmony Biosciences Holdings Inc-Aktie (HRMY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Harmony Biosciences Holdings Inc-Aktie (HRMY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kapadia Sandip | CHIEF FINANCIAL OFFICER |
Jan 25 '26 |
Option Exercise |
0.00 |
4,725 |
0 |
4,725 |
| Kapadia Sandip | CHIEF FINANCIAL OFFICER |
Jan 24 '26 |
Option Exercise |
0.00 |
3,813 |
0 |
3,813 |
| Serafin Andrew | CHIEF STRATEGY OFFICER |
Jan 25 '26 |
Option Exercise |
0.00 |
2,600 |
0 |
2,600 |
| Serafin Andrew | CHIEF STRATEGY OFFICER |
Jan 24 '26 |
Option Exercise |
0.00 |
2,500 |
0 |
2,500 |
| Budur Kumar | CHIEF MEDICAL OFFICER |
Jan 25 '26 |
Option Exercise |
0.00 |
2,662 |
0 |
2,662 |
| Budur Kumar | CHIEF MEDICAL OFFICER |
Jan 24 '26 |
Option Exercise |
0.00 |
2,188 |
0 |
2,188 |
| Dayno Jeffrey M. | PRESIDENT, CEO |
Jan 25 '26 |
Option Exercise |
0.00 |
13,000 |
0 |
13,000 |
| Dayno Jeffrey M. | PRESIDENT, CEO |
Jan 24 '26 |
Option Exercise |
0.00 |
10,500 |
0 |
10,500 |
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):